{"id":"darvocet-then-placebo-then-opana","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Constipation"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Drowsiness"},{"rate":null,"effect":"Respiratory depression"}]},"_chembl":{"chemblId":"CHEMBL1200794","moleculeType":"Small molecule","molecularWeight":"337.80"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Darvocet then placebo then opana","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:47:27.708175+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:47:33.018893+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Darvocet then placebo then opana","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:47:33.315273+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Opioid receptors; mu/kappa/delta agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:47:34.365611+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200794/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:47:34.022660+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Darvocet and Opana are both opioid analgesics that bind to mu-opioid receptors in the central nervous system to reduce pain perception. This appears to be a clinical trial design comparing an older opioid (Darvocet), a placebo control, and a more potent opioid (Opana) to assess pain relief outcomes and tolerability.","oneSentence":"This is a study comparing three opioid pain medications: Darvocet (propoxyphene/acetaminophen), placebo, and Opana (oxymorphone), to evaluate their relative efficacy and safety in pain management.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:44:10.581Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:47:35.720643+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Moderate to severe pain (trial comparison study)"}]},"trialDetails":[{"nctId":"NCT00652093","phase":"PHASE4","title":"Lumbar Stenosis Outcomes Research II","status":"TERMINATED","sponsor":"University of Rochester","startDate":"2008-03","conditions":"Lumbar Spinal Stenosis","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL1200794"},"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["opana: oxymorphone HCL","darvocet: propoxyphene/acetaminophen","placebo: inactive drug"],"phase":"marketed","status":"active","brandName":"Darvocet then placebo then opana","genericName":"Darvocet then placebo then opana","companyName":"University of Rochester","companyId":"university-of-rochester","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a study comparing three opioid pain medications: Darvocet (propoxyphene/acetaminophen), placebo, and Opana (oxymorphone), to evaluate their relative efficacy and safety in pain management. Used for Moderate to severe pain (trial comparison study).","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:47:35.720643+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}